NDC 42023-106

Brevital Sodium

Methohexital Sodium

Brevital Sodium is a Intramuscular; Intravenous; Rectal Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Methohexital Sodium.

• Product ID: 42023-106_065314be-7805-4e23-a057-af5ac65e289c
• NDC: 42023-106
• Product Type: Human Prescription Drug
• Proprietary Name: Brevital Sodium
• Generic Name: Methohexital Sodium
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAMUSCULAR; INTRAVENOUS; RECTAL
• Marketing Start Date: 2007-11-01
• Marketing End Date: 2021-01-31
• Marketing Category: NDA / NDA
• Application Number: NDA011559
• Labeler Name: Par Pharmaceutical, Inc.
• Substance Name: METHOHEXITAL SODIUM
• Active Ingredient Strength: 3 g/1
• Pharm Classes: Barbiturate [EPC],Barbiturates [CS]
• DEA Schedule: CIV
• NDC Exclude Flag: N

Packaging

NDC 42023-106-01

1 VIAL in 1 CARTON (42023-106-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

• Marketing Start Date: 2007-11-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 42023-106-01 [42023010601]

Brevital Sodium INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA011559
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2007-11-01

Drug Details

Active Ingredients

Ingredient	Strength
METHOHEXITAL SODIUM	2.5 g/1

OpenFDA Data

• SPL SET ID: eccd8340-ead3-4363-8902-0c19d33aa2ac
• Manufacturer:
  • Par Pharmaceutical, Inc.
• UNII:
  • 60200PNZ7Q
• RxNorm Concept Unique ID - RxCUI:
  • 1244638
  • 1244233
• UPC Code:
  • 0342023106018
  • 0342023105011

Pharmacological Class

• Barbiturate [EPC]
• Barbiturates [CS]

NDC Crossover Matching brand name "Brevital Sodium" or generic name "Methohexital Sodium"

NDC	Brand Name	Generic Name
42023-105	Brevital Sodium	methohexital sodium
42023-106	Brevital Sodium	methohexital sodium